Cargando…
Calcineurin Inhibition at the Clinical Phase of Prion Disease Reduces Neurodegeneration, Improves Behavioral Alterations and Increases Animal Survival
Prion diseases are fatal neurodegenerative disorders characterized by a long pre-symptomatic phase followed by rapid and progressive clinical phase. Although rare in humans, the unconventional infectious nature of the disease raises the potential for an epidemic. Unfortunately, no treatment is curre...
Autores principales: | Mukherjee, Abhisek, Morales-Scheihing, Diego, Gonzalez-Romero, Dennisse, Green, Kristi, Taglialatela, Giulio, Soto, Claudio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951383/ https://www.ncbi.nlm.nih.gov/pubmed/20949081 http://dx.doi.org/10.1371/journal.ppat.1001138 |
Ejemplares similares
-
De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype
por: Barria, Marcelo A., et al.
Publicado: (2009) -
Correction: De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype
por: Barria, Marcelo A., et al.
Publicado: (2013) -
Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
por: Mukherjee, Abhisek, et al.
Publicado: (2017) -
A Role for Calcineurin in Alzheimer’s Disease
por: Reese, Lindsay C, et al.
Publicado: (2011) -
Development of a novel pharmacophore model to screen specific inhibitors for the serine-threonine protein phosphatase calcineurin
por: Mukherjee, Abhisek, et al.
Publicado: (2022)